Ketogenic diet protects the hippocampus from kainic acid toxicity by inhibiting the dissociation of bad from 14-3-3

Journal of Neuroscience Research

Volumn 84, Issue 8, 2006, Pages 1829-1836

  Noh, Hae Sook ^a   Kim, Yoon Sook ^a   Kim, Young Hee ^a   Han, Jae Yoon ^a   Park, Chang Hwan ^a   Kang, Ahn Ki ^b   Shin, Hee Suk ^b   Kang, Sang Soo ^a   Cho, Gyeong Jae ^a   Choi, Wan Sung ^a,b  

^a Gyeongsang National University   (South Korea)

^b Gyeongsang National University School of Medicine   (South Korea)

Author keywords

Akt; Bax; Bcl xL; Epilepsy; p Bad

Indexed keywords

CASPASE 3; KAINIC ACID; PHOSPHOPROTEIN; PROTEIN 14 3 3; PROTEIN BAD; PROTEIN KINASE B; SERINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TOXICITY; CONTROLLED STUDY; DISSOCIATION; HIPPOCAMPUS; KETOGENIC DIET; MALE; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SEIZURE;

14-3-3 PROTEINS; ANIMALS; BCL-ASSOCIATED DEATH PROTEIN; BLOTTING, WESTERN; BRAIN INJURIES; CASPASE 3; DIET, CARBOHYDRATE-RESTRICTED; GENE EXPRESSION REGULATION; HIPPOCAMPUS; IMMUNOPRECIPITATION; KAINIC ACID; MALE; MICE; MICE, INBRED ICR;

EID: 33845417298     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.21057     Document Type: Article

References (45)

1. Adams JM, Cory S. 1998. The Bcl2 protein family: arbiter? of cell survival. Science 281:1322-1326.
2. Alessi DR, James SR, Downes CP, Holmes AB, Gaffiney PRJ, Reese CB, Cohen P. 1997. Characterization of a 3-phosphoinositide-dependent protein kinase which phosporylates and activates protein kinase B. Curr Biol 7:261-269.
3. Baran H, Hortnagl H. 1989. Kainic acid-induced seizures: potentiation by alpha-methyl-p-tyrosine. Brain Res 495:253-260.
4. Ben-Ari Y. 1985. Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy. Neuroscience 14:375-403.
5. Bolanos AR, Sarkisian M, Yang Y, Hori A, Helmers SL, Mikati M, Tandon P, Stafstrom CE, Holmes GL. 1998. Comparison of valproate and phenobarbital treatment after status epilepticus in rats. Neurology 51:41-48.
6. Cheng CM, Kelley B, Wang J, Strauss D, Eagles DA, Bondy CA. 2003. A ketogenic diet increases brain insulin-like growth factor receptor and glucose transporter gene expression. Endocrinology 144:2676-2682.
7. Chiang CW, Kanies C, Kim KW, Fang WB, Parkhurst C, Xie M, Henry T, Yang E. 2003. Protein phosphatase 2A deposphorylation of phosphoserine 112 plays the gatekeeper role for BAD-mediated apoptosis. Mol Cell Biol 23:6350-6362.
8. Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Greenberg ME. 1997. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91:231-241.
9. Datta SR, Katsov A, Hu L, Petros A, Fesik SW, Yaffe MB, Greenberg ME. 2002. 14-3-3 proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation. Mol Cell 6:41-51.
10. Dramsi S, Scheid MP, Maiti A, Hojabrpour P, Chen X, Chubert K, Goodlett DR, Aebersold R, Duronio V. 2002. Identification of novel phosphorylation site, Ser-170, as a regulator of bad proapoptotic activity. J Biol Chem 272:28882-28888.
11. Erol E, Kumar LS, Cline GW, Shulman GI, Kelly DP, Binas B. 2004. Liver fatty acid binding protein is required for high rates of hepatic fatty acid oxidation but not for the action of PPAR alpha in fasting mice. FASEB J 18:347-349.
12. Freeman J, Veggiotti P, Lanzi G, Tagliabue A, Perucca E, Institute of Neurology IRCCS C. Mondino Foundation. 2006. The ketogenic diet: from molecular mechanisms to clinical effects. Epilepsy Res 68:145-180.
13. Fukunaga K, Kawano T. 2003. Akt is a molecular target for signal transduction therapy in brain ischemic insult. J Pharmacol Sci 92:317-327.
14. Harada H, Andersen JS, Mann M, Terada N, Korsmeyer SJ. 2001. p70S6 kinase signals cell survival as well as growth, inactivating the proapoptotic molecule BAD. Proc Natl Acad Sci U S A 98:9666-9670.
15. Henshall DC, Simon RP. 2005. Epilepsy and apoptosis pathways. J Cerebral Blood Flow Metab 25:1557-1572.
16. Henshall DC, Araki T, Schindler CK, Lan JQ, Tiekoter KL, Taki W, Simon RP. 2002. Activation of Bcl-2-assoaciated death protein and counter response of Akt within cell populations during seizure-induced neuronal death. J Neurosci 22:8458-8465.
17. Hu RQ, Koh S, Torgerson T, Cole AJ. 1998. Neuronal stress and injury in the C57/BL mice after systemic kainic acid administration. Brain Res 810:229-240.
18. Kelekar A, Chang BS, Harlan JE, Fesik SW, Thompson CB. 1997. Bad is a BH3 domain-containing protein that forms an inactivating dimmer with Bcl-xL. Mol Cell Biol 17:7040-7046.
19. Lizcano JM, Morrice N, Cohen P. 2000. Regulation of BAD by cAMP-dependent protein kinase is mediated via phosphorylation of novel site, Ser 155. Biochem J 349:547-557.
20. Martin H, Rostas J, Patel Y, Aitken A. 1994. Subcellular localisation of 14-3-3 isoforms in rat brain using specific antibodies. J Neurochem 63:2259-2265.
21. Masters SC, Yang H, Datta SR, Greenberg ME, Fu H. 2001. 14-3-3 Inhibits Bad-induced cell death through interaction with serine-136. Mol Pharmacol 60:1325-1331.
22. Mattson MP. 2000. Apoptosis in neurodegenerative disorders. Nat Rev Mol Cell Biol 1:120-129.
23. Meller R, Schindler CK, Chu XP, Xiong ZG, Cameron JA, Simon RP, Henshall DC. 2003. Seizure-like activity leads to the release of BAD from 14-3-3 protein and cell death in hippocampal neurons in vitro. Cell Death Differ 10:539-547.
24. Mikati MA, Holmes GL, Chronopoulos A, Hyde P, Thurber S, Gatt A, Werner S, Stafstrom CE. 1994. Phenobarbital modifies seizure-related brain injury in the developing brain. Ann Neurol 36:425-433.
25. Muller-Schwarze AB, Tandon P, Liu Z, Yang Y, Holmes G, Stafstrom CE. 1999. Ketogenic diet reduces spontaneous seizures and mossy fiber sprouting in the kainic acid model. Neuroreport 10:1517-1522.
26. Noh HS, Kim YS, Lee HP, Chung KM, Kim DW, Kang SS, Cho GJ, Choi WS. 2003. The protective effect of a ketogenic diet on kainic acid-induced hippocampal cell death in the male ICR mice. Epilepsy Res 53:119-128.
27. Noh HS, Lee HP, Kim DW, Kang SS, Cho GJ, Rho JM, Choi WS. 2004. A cDNA microarray analysis of gene expression profiles in rat hippocampus following a ketogenic diet. Brain Res Mol Brain Res 129:80-87.
28. Noh HS, Kang SS, Kim DW, Kim YH, Park CH, Han JY, Cho GJ, Choi WS. 2005. Ketogenic diet increases calbindin-D28k in the hippocampi of male ICR mice with kainic acid seizures. Epilepsy Res 65:153-159.
29. Noshita N, Lewen A, Sugawara T, Chan PH. 2001. Evidence of phosphorylation of Akt and neuronal survival after transient focal cerebral ischemia in mice. J Cereb Blood Flow Metab 21:1442-1450.
30. Rho JM, Kim DW, Robbins CA, Anderson GD, Schwartzkroin PA. 1999. Age-dependent differences in flurothyl seizure sensitivity in mice treated with a ketogenic diet. Epilepsy Res 37:233-240.
31. Schindler CK, Shinoda S, Simon RP, Henshall DC. 2004. Subcellular distribution of Bcl-2 family proteins and 14-3-3 within the hippocampus during seizure-induced neuronal death in the rat. Neurosci Lett 356:163-166.
32. Shinoda S, Schindler CK, Quan-Lan J, Saugstad JA, Taki W, Simon RP, Henshall DC. 2003. Interaction of 14-3-3 with Bid during seizure-induced neuronal death. J Neurochem 86:460-469.
33. Simonian NA, Getz RL, Leveque JC, Konradi C, Coyle JT. 1996. Kainic acid induced apoptosis in neurons. Neuroscience 75:1047-1055.
34. Sokoloff L. 1973. Metabolism of ketone bodies by the brain. Annu Rev Med 24:271-280.
35. Stafstrom CE. 1999. Animal models of the ketogenic diet: what have we learned, what can we learn? Epilepsy Res 37:241-259.
36. Stafstrom CE, Bough KJ. 2003. The ketogenic diet for the treatment of epilepsy: a challenge for nutritional neuroscientists. Nutr Neurosci 6:67-79.
37. Subramanian RR, Masters SC, Zhang H, Fu H. 2001. Functional conservation of 14-3-3 isoforms in inhibiting bad-induced apoptosis. Exp Cell Res 271:142-151.
38. Sullivan PG, Rippy NA, Dorenbos K, Concepcion RC, Agarwal AK, Rho JM. 2004. The ketogenic diet increases mitochondrial uncoupling protein levels and activity. Ann Neurol 55:576-580.
39. Swink TD, Vining EP, Freeman JM. 1997. The ketogenic diet: 1997. Adv Pediatr 44:297-329.
40. Todorova MT, Tandon P, Madore RA, Stafstrom CE, Seyfried TN. 2000. The ketogenic diet inhibits epileptogenesis in EL mice: a genetic model for idiopathic epilepsy. Epilepsia 41:933-940.
41. Uhlemann ER, Neims AH. 1972. Anticonvulsant properties of the ketogenic diet in mice. J Pharmacol Exp Ther 180:231-238.
42. Weiss S, Cataltepe O, Cole AJ. 1996. Anatomical studies of DNA fragmentation in rat brain after systemic kainate administration. Neuroscience 74:541-551.
43. Woolley DE, Timiras PS. 1962. Estrous and circadian periodicity and electroshock convulsions in rats. Am J Physiol 202:379-382.
44. Yang E, Zha J, Jockel J, Boise LH, Thompson CB, Korsmeyer SJ. 1995. Bad, a heterodimeric partner for Bcl-xL and Bcl-2, displace Bax and promotes cell death. Cell 80:285-291.
45. Zha J, Harada H, Yang E, Jockel J, Korsmeyer SJ. 1996. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not Bcl-xL. Cell 87:619-628.